In recent years, chemotherapy-induced cardiovascular disease has emerged as a significant cause of mortality among cancer ...

A scientific statement has been published by the AHA regarding cardiovascular toxicity in patients treated for childhood cancer.

"Anthracyclines should be considered in patients with high genomic-risk, hormone receptor-positive [HR+], node-negative disease," she concluded. The study added to an ongoing debate about the role ...